There is still no satisfactory explanation for the low catalytic activity of tissue factor (TF)/factor Vll(a1 complexes towards coagulation factor X, as found on the apical surface side of cell layers. It has been hypothesized that TF exists in a latent form. Layers of cultured human smooth muscle cells, constitutively expressing TF, were immunogold-labeled for TF in situ and processed for electron microscopy. We showed that, besides internalization and accumulation in lysosomallike structures, TF remained associated with noncoated, flask-shaped microinvaginations of the plasma membrane. These invaginations were identified as caveolae. In regions I ~~, 2 , 4 , . 5 although induction of endothelial TF has been
T IS GENERALLY considered that contact between plasma factor VII(a) and its receptor and cofactor, tissue factor (W), is sufficient to initiate coagulation in v~v o . "~ TF is a transmembrane glycoprotein. In the normal state, vascular TF is located on cells in the adventitia and variably on cells in the media."6 Quiescent endothelium does not show detectable Besides regulation at the transcriptional it is thought that TF activity is modulated by either alterations in the phospholipid composition of the surface in the proximity of the TF protein'"-" or specific inhibiti~n.'~."
However, there is still no satisfactory explanation for the low catalytic activity of TF/factor VII(a) complexes, as found on the apical surface side of cell layer^.".'^ It has been hypothesized that TF exists in a latent form."."
In this study, we show that TF, constitutively expressed on layers of cultured human smooth muscle cells (SMCs)?'" is associated with noncoated microinvaginations of the plasma membrane that are identified as caveolae. Detachment of cells leads to a more open status of these structures, concomitantly with an increase of TF activity. in which intercellular contacts were interrupted, more TFpositive caveolae were observed. Enzymatically detached smooth muscle cells exhibited a similar enlargement of caveolar structures. Concomitantly, an increase of catalytic activity of apically formed TF/Vlla complexes towards factor X was found on the suspended cells. We speculate that caveolae-associated TF may function as a latent pool of procoagulant activity, which can rapidly be activated at sites in which vessel wall integrity is lost. 0 1996 by The American Society of Hematology. M S , Bagsvaerd, Denmark). Human coagulation factor X was obtained from Kordia BV (Leiden, The Netherlands). Mouse monoclonal antibodies against human TF (#4503, #4504, and #4506) were obtained from American Diagnostica Inc (Greenwich, CT). Nonimmune mouse IgGl was purchased from Becton Dickinson (Mountain View, CA). Rabbit polyclonal anticaveolin antibody was obtained from Transduction Laboratories (Lexington, KY). Nonimmune rabbit Igs were from Dakopatts A/S (Glostrup, Denmark). Goat antimouse antibodies coupled to 10-nm gold particles and goat antirabbit antibodies coupled to S-nm gold particles were obtained from Sanver TECH (Boechout, Belgium).
Culture of SMCs. SMCs, which had overgrown the endothelial cultures derived from umbilical cord vessels, were cultured as described The SMCs were differentiated from endothelial cells by their spindle shape, much larger size, and reactivity with an antibody against a-smooth muscle actin, whereas no reactivity with an antibody against von Willebrand factor was Culture medium consisted of RPM1 1640 (GIBCO, Paisley, UK) supplemented with 20% heat-inactivated pooled human serum, 2 mmol/L L-glutamine, S U/mL heparin, SO pg/mL EC growth factor supplement extracted from bovine hypothalamus;' 1 0 0 p g h L streptomycin, and 100 IUlmL penicillin.
Ultrastructurul studies. SMCs were cultured in Lab-tek 8 chambedslides (Miles Scientific, Naperville, IL; Mulder et al, manuscript submitted). Briefly, 30% (wt/vol) gelatin was sterilized by autoclavation and then chilled to 65°C. Subsequently, small wells of Lab-tek 8 chamber/slides were coated with 20 pL of the viscous gelatin solution and incubated at room temperature for 30 minutes, followed by fixation in O S % glutaraldehyde overnight. Before seeding the cells, the wells were washed thoroughly.
For localization of TF, confluent SMC layers were labeled with 50 pg/mL mouse anti-TF antibodies (#4S03) for 1 hour at 4°C in culture medium and then washed and incubated with gold (10 nm)-labeled goat antimouse IgC (20 pglmL) in culture medium for 1 hour at 4°C or 37°C. Other layers were fixed before labeling with antibodies against T F (a combination of #4S04 and #4506) at room temperature by immersion in 0.2% glutaraldehyde plus 2% paraformaldehyde in 0.1 mol/ L phosphate buffer at 4°C overnight. To minimize nonspecific binding of the antibodies, the cells were washed in phosphate-buffered saline (PBS; 0.14 mol/L NaCL, 0.01 moUL phosphate, pH 7.4) with 0.1 S molL glycine for 15 minutes and subsequently in a buffer of 0.01 mol/L Tris-HC1, pH 7.4, with 2% dry milk solids for 60 minutes at room temperature. In control samples, nonimmune mouse IgGl was added instead of anti-TF antibodies.
For quantification of TF labeling, the percentages of gold particles associated with caveolae, with plasmalemma proper, or with coated pits were determined. For each labeling condition, more than S00 gold particles were scored. Additionally, the percentages of more than S00 caveolae, which were labeled, were determined.
For colocalization of TF with caveolin, unfixed SMC layers were immunogold-labeled with anti-TF antibodies (#4503) at 37"C, as described above. The layers were then fixed with 3.5% formaldehyde diluted in PBS Overnight at 4"C, followed by permeabilization in 0.2% Triton X-100 for 10 minutes at room temperature. After washing three times for 5 minutes each with PBS and once with 0.2% bovine serum albumin in PBS (PBSIBSA) for 10 minutes, the cells were labeled with 5 pg/mL rabbit antibodies against caveolin for 60 minutes at room temperature in PBSIBSA, washed, and then incubated with gold (5 nm)-labeled goat antirabbit IgG (20 pg/mL) for 60 minutes in PBS/BSA. In control samples, nonimmune rabbit IgG was added instead of the anticaveolin antibody.
A modification of a method described for lymphocyte^^^ was used to examine the cells' ultrastructure. Before embedding, in all cases, layers were washed thoroughly and fixed in 2% glutaraldehyde. Thin sections were finally stained with uranyl acetatehethy1 cellulose and lead citrate for examination in a Philips 201 electron microscope (Philips, Eindhoven, The Netherlands).
TF activity. Layers of SMCs were grown to confluence in 24well culture dishes (Costar, Cambridge, MA). Factor VIIa (final concentration, 10 nmol/L) and X (final concentration, 50 nmol/L) were added in assay buffer (10 mmol/L HEPES, 137 mmol/L NaCI, 4 mmol/L KCI, 1 l mmoVL a,D-glucose, 5 mg/mL of ovalbumin and 2.5 mmoln CaCI2, pH 7.45). Serial subsamples were subsequently withdrawn from the reaction mixture at 2-minute intervals to measure factor X activation spectroph~tometrically.~'.~~ After 10 minutes, the cells were washed in assay buffer, detached by brief treatment with 0.05 mg/mL chymotrypsin for 5 minutes, centrifugated, and resuspended in assay buffer. Subsequently factor X (50 nmol/ L) was added and factor Xa generation was measured, with or without adding additional factor VIIa in the assay. Controls consisted of layers preincubated with inhibitory anti-TF antibodies (50 pg/mL) for 30 minutes at 37°C. The viability of the detached cells, tested by light microscopic measurement of trypan blue exclusion, was 98% L 1%. Cell counts were determined using a Coulter counter. Additionally, possible effects of chymotrypsin treatment on the activity of TF/factor VIIa complexes were examined. SMC layers were apically incubated with factor VIIa, washed, and lifted from the dishes either by chymotrypsin treatment, as described above, or by scraping. After centrifugation, cells were lysed by three freezekhaw cycles (-8OoC/37"C) in assay buffer and subsequently tested for factor X activation activity without adding additional factor VIIa in the assay.
RESULTS

Subcellular localization of TF in layers of SMCs.
On adherent SMCs immunogold-labeled for TF at 4°C and processed in situ for electron microscopy, we found that, besides presence on plasmalemma proper and within coated pits,25 particles were located within or nearby smaller, noncoated invaginations of the plasma membrane ( Fig 1A) . Morphologically, the noncoated invaginations were recognized as caveolae (also known as plasmalemma vesicles) by their characteristic 50to 60-nm size and flask shape.26,27 When labeling was performed at 37"C, we observed that, besides internalization, gold-labeled TF remained associated with the noncoated plasma membrane invaginations ( Fig  1B) . Even an increase in the relative number of gold particles associated with caveolae could be observed (Table  l) . Coated pits were consistently devoid of label. Incubation of layers with nonimmune, mouse IgG instead of specific anti-TF antibodies gave no labeling (Fig 1C) .
It was excluded that TF was clustered in and around caveolae only as a result of cross-linking antibodies:' because when cells were fixed (2% paraformaldehyde and 0.2% glutaraldehyde) before labeling, gold particles could still be found associated with caveolae (Fig 2) . However, caveolae were labeled to a much lesser extent (Table  1) and label was more often located around instead of physically within caveolae in fixed cells. Therefore, we cannot exclude any effect of immunolabeling on caveolar localization of TF in unfixed cells, although alternative mechanisms, including lower accessibility of (immunogold-conjugated) antibodies to caveolar located TF, might have been responsible for the different distribution of gold label in fixed cells.
Further, in line with previously reported data,29 we found in regions of labeled SMC layers in which intercellular contacts were interrupted more TF-positive caveolae ( Fig 3A) . Occasionally, label was present in coated pits or coated vesicles at these sites.
Subcellular localization of TF in suspended SMCs. To further support the detachment-related phenomena, as described above, we examined cells in suspension. After immunogold-labeling of TF at the apical side of SMC layers at 37"C, cells were washed in isotonic PBS and detached by treatment with 0.05 mg/mL chymotrypsin in PBS for 5 minutes at 37°C. Subsequently, the cells were immediately fixed and processed for electron microscopy (Fig 3B) . Accordingly, suspended cells exhibited extensive dilated caveolaelike structures that were preferentially associated with apparently intracellular located tubular and vesicular structures. Frequently, clusters of caveolae were seen to surround a central vacuole, a profile characteristic for caveolar enlarge-n~ent.~' These apparently intracellular located, TF-positive, caveolae-like structures were further characterized by colocalization of caveolin3' (Fig 4) .
Factor Xa generation by TFJactor Vlla complexes on the surface of layers and suspended SMCs. To determine the functional consequences of cell detachment for TF, layers of SMCs were incubated with factor VIIa and X and generation of activated factor X (Xa) was measured ( Fig 5) . Subsequently, these layers were washed and detached, and cells were resuspended in assay buffer. After the addition of factor SMC layers were labeled at 4°C with anti-TF antibodies (#4503), washed, and subsequently incubated with gold-labeled antibodies against anti-TF antibodies, either at 4°C or 37°C. Other layers were fixed overnight with 2% paraformaldehyde and 0.2% glutaraldehyde at 4°C before immunogold labeling of TF (#4504 and #4506) at room temperature. X, generation of factor Xa was measured with or without adding additional factor VIIa in the assay.
Increased activity of apically formed TF/factor VIla complexes could be observed after detachment of the cells, which could be apically inhibited with anti-TF antibodies. A further increase of TF activity by adding additional factor VIIa in the assay of detached cells showed free TF sites that might have been inaccessible to factor VIIa on the apical side or located on the abluminal surface side of the cell layers. Mixing experiments, as described by Rao et a13' indicated that no unbound factor VIIa or antibody was present after washing of the cells (data not shown).
We also excluded the possibility that the increase of activity of the TF/factor VIIa complexes could have resulted from removal of a cell-associated inhibitor of the TF pathway by chymotrypsin treatment. Lysate of cells apically incubated with factor VIIa showed a TF/factor VIIa activity of 3.56 2 0.19 nmol Xa/min/lO" cells (means 5 SEM of triplicate determinations) when cells were lifted from the dish by scraping versus 3.16 2 0.06 nmol Xa/min/lOh cells when cells were detached by chymotrypsin treatment.
DISCUSSION
Previous studies have shown submaximal catalytic activity of TF/factor VII(a) complexes on the intact apical surface side of cell layers.'".'' Increase of activity can be induced by various conditions, including exposure of cells to membrane perturbing agents, such as hydrogen peroxide33 or activated Unfixed SMC layers were immunogold-labeled with anti-TF antibodies (#4503) at 37°C (arrows). The layers were then washed and fixed in 3.5% formaldehyde followed by permeabilization in 0.2% Triton X-100. Subsequently, the cells were washed and labeled with 5 pg/mL rabbit antibodies against caveolin followed by labeling with gold (5 nml-labeled goat antirabbt IgG (20 pg/mLl larrowheads). (B) There was negligible labeling with 5-nm gold particles when the formaldehyde-fixed cells were incubated with nonimmune rabbit Igs instead of anticaveolin antibodies (arrowhead). Scale bar indicates 100 nm. complement," and by total cell lyse^.'^'.'"^'^ It is generally considered that increase of procoagulant activity associated with cell surfaces can be related to a redistribution of membrane lipids, including availability of anionic phospholipids in the proximity to TF."'.I3 Alternatively, it has been shown that surface-expressed procoagulant TF activity increases after exposure of cells to proteolytic enzymes and existence of a cryptic pool of TF has been suggested.lx.'"
In this study, we showed the presence of TF constitutively expressed on layers of cultured SMCs, within or near noncoated microinvaginations of the plasma membrane, especially in regions in which cell-cell contacts had been disrupted. These microinvaginations were recognized as ~aveolae.'~."~~'' Additionally, TF was internalized, probably through coated pits," and accumulated in compartments, belonging to the route of degradation, ie, lysosom a ll'k I e Struc-
tures.
We further observed in apically labeled and enzymatically detached SMCs that TF was frequently associated with an extensive, dilated caveolae-like system. a pattern comparable to that seen in layers at sites in which cell contacts were disrupted. Most of these caveolae-like structures were apparently located within the suspended cells. However, because these structures contained caveolin and could be found deep within SMC layers when TF labeling was performed at 4°C (data not shown), we think that these structures are most likely caveolae associated with invaginated plasmalemma regions.
It can be hypothesized that loss of all TF, through its internalization and degradation, might be prevented by excluding TF molecules from coated pits due to association with caveolar structures. Possibly different transit pathways of TF could be mediated by cross-linking antibodies, as has been suggested for GPI-linked proteins,'x or by actions of other coagulation factors andor their inhibitors. Of special interest are. besides factor VII(a), factor IX and X, because different activity profiles have been observed for the latter two factors.." Alternatively, although the capability of caveolae to be internalized has been que~tioned.~~.~" we cannot exclude (eventual) transfer of caveolar TF to the route of degradation.3x"' Possible internalization of caveolar-associated TF may have been slowed down or prevented by release of cell tension in detached cells allowing visualization of abundant TF-positive caveolar structures (Fig 3) .
Finally, we found that catalytic activity of TF/factor VIIa complexes, formed on the apical side of SMC layers, increased after bringing cells in suspension, which could be inhibited by antibodies at the apical side. Obviously, factor VIIa as well as antibodies against TF are accessible to T F at the apical surface side, despite the submaximal catalytic activity of the TF/factor VIIa complexes towards factor X. These results are consistent with prior findings" showing two functionally distinct classes of TF/factor VIIa complexes on intact cell layers, ie, a small number of complexes exhibiting activity towards factor X and a large number of complexes only showing activity towards factor X after lysis of the cells. Le et allh also showed that in the layer setting both classes exhibited activity towards a peptidyl substrate. Furthermore, more recent data have also indicated that release of cell tension coincided with increase of TF a~tivity.~' It remains to be answered whether caveolar location of TF has functional consequences. Of special interest in this context is its possible colocalization with other caveolar structures, such as a calcium or tyrosine kinases.s.l~46 On the other hand, specific absence of molecules, such as, for instance, heparan sulphates4' bearing the inhibitors TF pathway inhibit~r'~." and antithrombin III,4x may have implications for TF activity at caveolar sites.
We further speculate that the increase of TF/factor VIIa catalytic activity towards factor X, after detachment of cells, may be related to enlargement of caveolar structures. For instance, opening of TF-positive caveolar structures may result in an enhanced accessibility of factor X to TFNIIa complexes. Additionally, the presence of anionic sites is important, because factor X needs interaction with anionic phospholipids for efficient activation by TF/factor VIIa comp l e x e~.~~-"
Because caveolae are devoid of anionic sites," it could be possible that flattening of TF-positive caveolae achieves presence of anionic sites in the proximity of the TFlfactor VIIa complexes.
In conclusion, we showed that TF, expressed on layers of cultured human smooth muscle cells, is associated with caveolae. Furthermore, an enlargement of TF-positive caveolae concomitantly with an increase of activity of apically formed TF/factor VIIa complexes was seen after detachment of the cells.
We speculate that caveolae-associated TF may function as a latent pool of procoagulant activity, which can rapidly be activated at sites in which vessel wall integrity is lost.
